Chimeric Antigen Receptor T-cell (CAR-T) therapy represents a groundbreaking advancement in cancer treatment, leveraging genetically engineered T-cells to target and destroy malignant cells.
Expanding Clinical Applications and AdoptionThe CAR-T therapy market is experiencing substantial growth due to the increasing adoption of advanced immunotherapies across healthcare systems worldwide....
SPARK Website
English